July 9, 2025 03:22 AM GMT China Healthcare | Asia Pacific M Update A Potential 200% US Tariff on Pharmaceuticals - How Feasible Is It? Key Takeaways Generic drugs: There is currently an acute shortage of sterile injectables in the US. A report from the US FDA earlier this year highlighted 102 generic medicines, 70% of which were injectables, that were under-supplied from 2019-2024. The biggest categories were anesthesia, endocrinology, gastroenterology, oncology, and cardiovascular injections (note). Generi ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.It also includes access to the Zacks Style Scores. What a ...

Viatris (VTRS) , a global healthcare company, is scheduled to report first-quarter 2025 results on May 8, 2025.The Zacks Consensus Estimate for revenues is pegged at $3.24 billion, while the same for earnings is pinned at $0.50 per share. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar.)Factors to ConsiderThe company reports under four segments — Developed Markets, Emerging Markets, Japan, Australia and New Zealand (JANZ), and Greater China.Growth in Developed Markets, driven by stro ...